Expression of the thioredoxin system in interstitial lung disease.
The thioredoxin system containing thioredoxin (Trx) and thioredoxin reductase (TrxR) has profound effects on cell proliferation and protection against exogenous oxidants. The significance of the Trx system in human lung and lung diseases is, however, largely unresolved. Altogether, 66 specimens of human lung were investigated by immunohistochemistry for their expression of Trx and TrxR. The diseases included interstitial pneumonias such as usual interstitial pneumonia (UIP), desquamative interstitial pneumonia (DIP), and UIP associated with collagen vascular diseases (CVD-ILD), and granulomatous diseases such as sarcoidosis and allergic alveolitis. The ultrastructural localization of Trx and TrxR was analysed by immunoelectron microscopy. In healthy lung, Trx and TrxR were expressed in bronchial epithelium and alveolar macrophages. Trx and TrxR were highly concentrated in areas of metaplastic epithelium in UIP and in alveolar macrophages in DIP, though fibrotic areas in UIP were mainly negative. The expression of both enzymes was clearly weaker in CVD-ILD than in UIP. Granulomas of sarcoidosis showed moderate to intense Trx immunoreactivity. Ultrastructurally, Trx and TrxR were expressed diffusely in the cytosolic compartment and plasma membrane of metaplastic type II pneumocytes, macrophages, and bronchial epithelial cells. This study highlights the importance of Trx and TrxR in primary defence in bronchial epithelium, alveolar epithelium, and macrophages in human lung, but also indicates that elevated expression of these proteins may serve as markers of ongoing cell regeneration and inflammation.
Tiitto
Leena
L
Department of Internal Medicine, University of Oulu and Oulu University Hospital, Oulu, Finland. leena.tiitto@oulu.fi
Kaarteenaho-Wiik
Riitta
R
Sormunen
Raija
R
Holmgren
Arne
A
Pääkkö
Paavo
P
Soini
Ylermi
Y
Kinnula
Vuokko L
VL
D000542:Alveolitis, Extrinsic Allergic / Q000473:pathology; D001980:Bronchi / Q000473:pathology; D001992:Bronchoalveolar Lavage Fluid; D002462:Cell Membrane / Q000473:pathology; D003094:Collagen / Q000032:analysis; D003600:Cytosol / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008168:Lung / Q000473:pathology; D017563:Lung Diseases, Interstitial / Q000378:metabolism*; D016253:Microscopy, Immunoelectron / Q000379:methods; D017565:Sarcoidosis, Pulmonary / Q000473:pathology; D013880:Thioredoxin-Disulfide Reductase / Q000032:analysis; D013879:Thioredoxins / Q000032:analysis*; D014652:Vascular Diseases / Q000473:pathology
D013879:Thioredoxins; D003094:Collagen; D013880:Thioredoxin-Disulfide Reductase